Neuropharmacology & Neurotherapeutics
Fosphenytoin
Mar. 07, 2021
This is an image preview.
Start a Free Account
to view the full image.
-
Nearly 3,000 illustrations, including video clips of neurologic disorders.
-
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
-
Full spectrum of neurology in 1,200 comprehensive articles.
-
Listen to MedLink on the go with Audio versions of each article.
Assessing patients with known or possible exposure to botulinum toxin in conventional and contingency settings
When assessing the likelihood of botulism, consider clinical criteria and available epidemiologic data. Classify patients into a botulism likelihood category by clinical judgment. Additional information on clinical criteria is available. (Source: Rao AK, Sobel J, Chatham-Stephens K, Luquez C. Clinical guidelines for diagnosis and treatment of botulism, 2021. MMWR Recomm Rep 2021;70[2]:1-30. Public domain.)